Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 20,214 shares at $27.15 ($549K) on 2024-01-05, disclosed to the SEC on 2024-01-09.
Scheduled sale ($549k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.15 | 10,107 | $274K | 50.0% |
| 2 | $27.15 | 10,107 | $274K | 50.0% |
| Total | $27.15 avg | 20,214 | $549K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |